Full history for every metric is available with a Kvantra account
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 2,882 | 1,211 | 1,375 | 1,751 | 1,647 | 1,736 | 2,006 | 2,006 |
| Operating profit | £m | 225 | 225 | ||||||
| Net profit | £m | 245 | 253 | 236 | 190 | 188 | 143 | 97 | 97 |
| EPS reported | £ | 0.22 | 0.22 | ||||||
| Operating cashflow per share | £ | 0.54 | 0.53 | ||||||
| Capex per share | £ | 0.26 | 0.26 | ||||||
| FCF per share | £ | 0.28 | 0.27 | ||||||
| Free cash flow | £m | 122 | 122 | ||||||
| Net debt | £m | 894 | 894 | ||||||
| Book value equity | £m | 1,598 | 1,598 | ||||||
| Book value per share | £ | 3.57 | 3.57 | ||||||
| Number of shares | m | 447.2 | 448.09 | ||||||
| DPS (TTM paid) | £ | 0.20 | 0.20 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 16.45 | - | ||||||
| P/B LTM | x | 1.00 | 1.55 | ||||||
| P/S LTM | x | 0.80 | 1.23 | ||||||
| P/FCF LTM | x | 13.12 | 20.30 | ||||||
| EV/EBITDA LTM | x | 6.43 | 9.47 | ||||||
| EV/Sales LTM | x | 1.27 | 1.68 | ||||||
| Earnings Yield LTM | % | 6.08% | 3.89% | ||||||
| FCF Yield | % | 7.62% | 4.93% | ||||||
| Quality | |||||||||
| ROE | % | 6.07% | 6.17% | ||||||
| ROIC | % | 5.27% | 5.27% | ||||||
| Operating margin | % | 11.22% | 11.22% | ||||||
| Gross margin | % | 18.15% | 46.91% | ||||||
| FCF/Sales | % | 6.08% | 6.08% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +83.33% | +83.33% | ||||||
| Sales Growth YoY | % | +15.55% | +15.55% | ||||||
| Net Income Growth YoY | % | -32.17% | -32.17% | ||||||
| FCF Growth | % | +183.72% | +183.72% | ||||||
| Operating Profit Growth | % | +112.26% | +112.26% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 5.50% | 3.54% | ||||||
| Dividend Growth | % | - | 0.00% | ||||||
| Payout Ratio | % | 89.45% | 90.72% | ||||||
| FCF/Debt | x | 0.09 | 0.09 | ||||||
| Net Debt/EBITDA | x | 2.39 | 2.67 | ||||||
| EBIT/Net interest | x | 3.95 | 3.95 | ||||||
| Net debt/market cap | % | 55.84% | 36.10% | ||||||
| Net debt/Equity | x | 0.56 | 0.56 | ||||||
| Gross debt/equity | x | 0.81 | 0.81 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Tate & Lyle plc (TATE.L)
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free